Nathan J. Dowden, President & COO: Entrada Therapeutics TRDA Sell · Filed 03/11

Trade details

Type: Insider sale
Amount: $155,216.7
Shares · price: 11,894 sh · $13.05 a share
Held after: 198,588 sh
Stock: Entrada Therapeutics TRDA
Person: Nathan J. DowdenPresident & COO
Trade date: 26/03/10
Filed: 26/03/11
Days to filing: 1 days

Sold 5.7% of holdings

Share of holding sold: 5.7%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 02/08~04/09

Nathan J. Dowden's recent trades

Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$230K
15,000 sh
$230K
Filed 05/04
Traded 05/04
Nathan J. DowdenPresident & COO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$217.5K
15,000 sh
$217.5K
Filed 05/04
Traded 05/04
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$40.6K
3,116 sh
$40.6K
Filed 03/11
Traded 03/09
Nathan J. DowdenPresident & COO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$188.8K
15,010 sh
$188.8K
Filed 03/09
Traded 03/09
Nathan J. DowdenPresident & COO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$13.6K
847 sh
$13.6K
Filed 24/09/30
Traded 24/09/26